Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ardelyx Inc
(NQ:
ARDX
)
6.090
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ardelyx Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
5 Under-the-Radar Penny Stocks With 100% Upside Potential
January 16, 2023
Most experts will advise you to steer clear of under the radar penny stocks – and for good reason. However, keep an eye on these.
Via
InvestorPlace
Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022
December 31, 2022
2022 would go down as one of the worst years for the financial markets. The sell-off has been all-pervasive, with stocks, bonds and cryptos all selling off indiscriminately. Even as high-fliers like...
Via
Benzinga
Ardelyx To Rally 160%? Here Are 10 Other Price Target Changes For Friday
December 30, 2022
Citigroup raised Ardelyx, Inc. (NASDAQ: ARDX) price target from $6 to $7. Citigroup analyst Yigal Nochomovitz maintained a Buy rating on the stock. Ardelyx shares rose 9.4% to $2.7685 on Friday.
Via
Benzinga
Dow Surges 250 Points; Jobless Claims Rise To 225,000
December 29, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Thursday.
Via
Benzinga
The 3 Biggest Opportunities for Penny Stock Investors in 2023
December 21, 2022
Investors should be able to profit from some of the biggest opportunities for penny stock investors identified in this column.
Via
InvestorPlace
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
December 19, 2022
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Via
Benzinga
Melco, Ardelyx And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
December 19, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Cosmos Health Inc. (NASDAQ: COSM) shares dipped 37.7% to $14.33 in...
Via
Benzinga
FDA Needs More Time For Ardelyx's Appeal To Rejection Of Kidney Disease Candidate
December 19, 2022
Via
Benzinga
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
December 19, 2022
Gainers AIM ImmunoTech Inc. (NYSE: AIM) shares rose 82.4% to $0.62 in pre-market trading. AIM ImmunoTech recently reported safety, tolerability and biological activity data for intranasal ampligen in...
Via
Benzinga
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
December 18, 2022
Biotech is one of the safest, recession-proof sectors on the market. It's why we're going after the hottest biotech stocks in the New Year.
Via
InvestorPlace
How Is The Market Feeling About Ardelyx?
December 07, 2022
Ardelyx's (NASDAQ:ARDX) short percent of float has risen 16.96% since its last report. The company recently reported that it has 8.59 million shares sold short, which is 4.62% of all regular shares...
Via
Benzinga
Planned Government Move To Expand Access To Drugs For End-Stage Renal Disease Patients Could Shine The Spotlight On Unicycive
December 07, 2022
In the U.S., reimbursement of dialysis expenses by the Centers for Medicare & Medicaid Services (CMS) is done using a prospective payment system (PPS) which enables the payout of a predetermined amount...
Via
Benzinga
EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In November 2022: Where Do Tesla, Apple, A Donald Trump-Linked SPAC Rank?
December 05, 2022
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.
Via
Benzinga
3 Biotech Stocks Smart Investors Should Be Buying Up Now
November 24, 2022
These three biotech stocks could be among the best ways to play this uncertain market for those looking for long-term growth.
Via
InvestorPlace
Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday
November 23, 2022
U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Is Ardelyx is A Buy After Slip in Early 2022
November 21, 2022
Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them
Via
MarketBeat
Exposures
Product Safety
CapitalGainsReport Sector Spotlight: Healthcare Penny Stocks On The Move (ARDX, WHSI, BNGO)
November 21, 2022
Via
AB Newswire
Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday
November 21, 2022
Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday.
Via
Benzinga
Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday
November 21, 2022
U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
2 Biotech Stocks That Can Rocket Higher in 2023, According to Wall Street
November 20, 2022
Recent analyst upgrades suggest these stocks can triple your money or better.
Via
The Motley Fool
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
November 18, 2022
Gainers PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 18, 2022
Via
Benzinga
Analyst Sees This Kidney Disease Company's Stock Could Rise Sixfold, But Lists Two Issues
November 18, 2022
Via
Benzinga
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
November 18, 2022
Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.
Via
Benzinga
Hillenbrand, Cisco, Macy's And Other Big Gainers From Thursday
November 18, 2022
U.S. stocks closed slightly lower on Thursday, with the S&P 500 dropping around 0.3%. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
November 17, 2022
Via
Benzinga
Nasdaq Down 60 Points; Alibaba Posts Upbeat Q2 Earnings
November 17, 2022
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 60 points on Thursday.
Via
Benzinga
Why Elevate Credit Shares Are Trading Higher By Over 71%? Here Are 43 Stocks Moving In Thursday's Mid-Day Session
November 17, 2022
Gainers Elevate Credit, Inc. (NYSE: ELVT) shares surged 71.2% to $1.8150 after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67...
Via
Benzinga
Fed Comments Continue To Weigh On Stocks Midday
November 17, 2022
Stocks are firmly lower midday, as bond yields rise following hawkish comments from St. Louis Federal Reserve President James Bullard.
Via
Talk Markets
12 Health Care Stocks Moving In Thursday's Intraday Session
November 17, 2022
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.